Suppr超能文献

体重减轻作为糖尿病视网膜病变的辅助管理策略。

Weight Reduction as an Adjunctive Management Strategy for Diabetic Retinopathy.

机构信息

John F. Hardesty MD Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri.

出版信息

Mo Med. 2022 Jan-Feb;119(1):42-48.

Abstract

As rates of global obesity and diabetes increase, diabetic retinopathy continues to grow as a frequent cause of visual impairment. Despite tremendous recent strides in therapy, a significant fraction of patients remain poorly responsive to modern interventions. Adjunctive therapy in such settings could be widely beneficial. A growing body of evidence suggests that weight reduction strategies for obesity-related diabetes have the potential to serve as important supplements to modern ophthalmic care for preservation of vision.

摘要

随着全球肥胖和糖尿病发病率的上升,糖尿病视网膜病变作为一种常见的致盲原因持续增加。尽管最近在治疗方面取得了巨大进展,但仍有相当一部分患者对现代干预措施反应不佳。在这种情况下,辅助治疗可能会广泛受益。越来越多的证据表明,针对肥胖相关糖尿病的减肥策略有可能成为现代眼科护理的重要补充,以保护视力。

相似文献

6
Lowering the risk of visual impairment and blindness.降低视力损害和失明的风险。
Diabet Med. 1998;15 Suppl 4:S47-50. doi: 10.1002/(sici)1096-9136(1998120)15:4+<s47::aid-dia739>3.3.co;2-j.
7
Screening for diabetic retinopathy.糖尿病视网膜病变筛查
Diabet Med. 1991;8 Spec No:S4-10. doi: 10.1111/j.1464-5491.1991.tb02148.x.
10
A critical review: Psychophysical assessments of diabetic retinopathy.一篇评论:糖尿病视网膜病变的心理物理学评估。
Surv Ophthalmol. 2021 Mar-Apr;66(2):213-230. doi: 10.1016/j.survophthal.2020.08.003. Epub 2020 Aug 29.

本文引用的文献

2
Once-Weekly Semaglutide in Adults with Overweight or Obesity.每周一次司美格鲁肽在超重或肥胖成人中的应用。
N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验